RBCC: Sobering Stats Show Growing Need for Affordable Alcoholism Treatment

HENDERSON, NV / ACCESSWIRE / April 4, 2016 / Recent scientific research has shown that alcohol is among the 10 most addictive drugs in existence, and trails only tobacco among legally obtainable substances and ranks nearly as potent as barbiturates when illegal ones are included. Rainbow Coral Corp. (OTCQB: RBCC) takes these findings as a serious sign that more research and treatment options are needed in order to successfully combat alcohol’s powerful addictive pull.

“Don’t misunderstand, we’re not calling for a return to Prohibition,” said RBCC CEO Kimberly Palmer, referring to the infamous attempt to outlaw the production and sale of all types of liquor in the U.S. from 1920 to 1933.

“Millions of people responsibly enjoy alcoholic beverages every day,” she said. “But there are a substantial number who become addicted to it and their bodies become trapped. They need help to kick this addiction. Unfortunately, that help often comes at a steep price and as a result, tens of thousands who want help are priced out of a solution. We aim to change this and are actively seeking partners to join us in developing and creating a series of low-cost, affordable alcoholism treatment centers to provide that help people desperately want.”

Recent studies have shown nearly 17 million Americans are now dependent on alcohol. However, only 2.5 million people have received treatment for their addiction, many due to cost concerns.

Research indicates that every dollar invested in effective substance abuse treatment yields government and society a 12-1 ratio of benefits in lower healthcare costs, reduced drug-related crime and decreased criminal justice costs.

For more information on RBCC’s initiatives, please visit www.rainbowbiocorp.com.

About Rainbow Biosciences

Rainbow Biosciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (RBCC). The Company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit www.rainbowbiocorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contact:

Rainbow Coral Corp.
Kimberly Palmer, 702-940-2345
President and CEO
info@rainbowcoral.com

Source: Rainbow Coral Corp.

ReleaseID: 438399